RELATIONSHIP BETWEEN PROSTATITIS AND CHLAMYDIA: Natural treatment

PROSTATE CANCER AND RADIOTHERAPY

General

The prostate cancer is cancer frequently touching the prostate, a  gland of the reproductive system of man. Cancer develops from the tissues of the prostate when cells there mutate and multiply out of control. These can then spread (  metastasize ) by migrating from the prostate to other parts of the body, especially the bones and lymph nodes in the pelvis.

     Malignant prostate cancer occurs independently of benign prostatic hyperplasia (BPH), or prostatic adenoma. In the vast majority of cases, it is an adenocarcinoma, especially of the acinar type. However, Dawasanté experts have a natural African plant-based treatment to permanently cure prostate cancer and the effects of radiotherapy. Click on the image below to discover this natural treatment. 

We deliver all over the world. 

For more information, you can contact our experts on +229 51374202 direct line or by WhatsApp at the same number.

Malignant prostate cancer can cause pain, difficulty urinating, and erectile dysfunction, among other things. Symptoms originating from an adenocarcinoma of the prostate often signal an advanced stage of the disease. Other prostate diseases cause the same symptoms: pelvic pain in prostatitis and difficulty urinating in BPH.

The most common treatments are surgery (radical prostatectomy),  radiotherapy  ( external radiotherapy and brachytherapy, in particular) and hormone therapy. The chemotherapy is used only in advanced forms. Here we will talk about radiotherapy. However, if you feel the need to be analyzed and treated, the Dawabio center is at your disposal to provide you with a treatment worthy of the name, natural of course.

Causes, risk factors

Its causes are still poorly understood, and could often be multiple:

• a genetic predisposition and the responsibility of certain genes seem possible but weakly correlated with the onset of the disease.
  In particular, a mutation on  chromosome 8  could explain the greater frequency of this cancer in black Americans;
• A link with bioavailable testosterone seems frequent. Charles Brenton Huggins  (inventor of hormone therapy for cancer) first (from the 1940s  and based on studies of metastatic prostate cancer) concluded that this cancer was induced by excess testosterone (or facilitated by this hormone). But more recently (the 2010s) the available data suggests that a more common cause is testosterone deficiency. Low testosterone before surgery for this cancer was linked in 2010 to an increased risk of tumor aggressiveness

• higher adult height correlates with a higher risk of prostate cancer;

• Nutritional factors have been mentioned. Certain foods seem to increase the risk of prostate cancer;
  According to several studies, the consumption of cow's milk increases this risk after 50 years, but other studies consider that this link is not significant or would be weak. The increased risk appears to be related to the increased level of IGF-1  in the blood, which itself correlates with milk consumption. Some studies suggest that casein may also have an effect on prostate cancer. Excessive dietary intake of phytanic acid from dairy products, especially butter has also been linked (2012) to a high risk of prostate cancer; for these reasons, in the name of the precautionary principle, the consumption of dairy products is no longer recommended for men. Overconsumption of calcium appears to be an established risk factor. Several scientific studies retain milk as a risk factor for hormone-dependent cancers such as those of the prostate, ovaries and breast.
  Other foods seem to play a protective role; the  lycopene  for example, dried fruits,  legumes ;

• similarly, physical exercise  may have a slightly protective effect;

• an endocrine disrupting effect   of certain products ( pesticides in  particular) could be involved;
• exposure to pesticides is a possible factor because agricultural populations are over-represented for this cancer, which remains etiologically poorly understood, and which therefore still requires research, in particular on gene-environment relationships and interactions  . The  cadmium  very present in phosphate fertilizers could also be involved;

• The  smoking ;
• a  viral infection  could sometimes be involved (unless it is favored by the process of cancerization or a decrease in immunity which also favored cancer);
  the XMRV retrovirus   ( Xenotropic MLV - Related Virus, variant of  MLV  ( murine leukemia virus responsible for leukemia in mice) and capable of infecting humans, was detected in 2006 in certain tumors of the prostate. It belongs to the gammaretrovirus genus already associated with leukemia and certain cancers in rodents, felines, and primates.
  According to a US study published in 2010 and involving 334 human prostate tissue samples, proteins appearing to come from this virus were found in 23% of cancerous tissue (against 4% of "healthy" samples). And they were more present in the more aggressive tumors. It remains to be identified whether the virus is the cause or one of the causes of these cancers or if it infects the prostate of patients because they have previously weakened immunity. If it is involved, we may have   additional biomarkers for this cancer or even new avenues of prevention;
• The  night work  is also mentioned (as for other cancers called "hormone").

• according to a study published in 2004, more frequent ejaculations are associated with a reduced risk of prostate cancer.

What are its symptoms and how is it detected?

This cancer is most often asymptomatic, that is to say, it is discovered when it does not cause any manifestation of its own. It is most often found:

• during blood tests including the study of  PSA  (specific antigen of the prostate, whose predictive value and use, without proven benefit in terms of  public health , have recently been called into question). PSA is a protein normally secreted by prostate cells, but a cancer cell secretes 10 times more than a normal cell. This property has raised many hopes in terms of screening. The blood level of PSA can however be increased by many other factors (prostate volume,  infections and / or inflammations, mechanical constraints (rectal examination, other) ...) or decreased by certain treatments for benign hypertrophy ( finasteride). The significance thresholds are therefore difficult to establish. It is accepted, however, that a PSA level of between 4 and 10 ng/ml is doubtful, but that it is clearly significant beyond. Some authors have proposed to relate the rate to the effective weight of the prostate or to assess the free PSA / total PSA ratio, or even the growth kinetics of the rate over 2 years.
  A still uncertain marker for screening, the PSA level is, on the other hand, an essential indicator for the monitoring and treatment of declared cancers;
• during a  digital rectal examination; performed routinely, or due to symptoms related to another disease (in particular benign prostatic hypertrophy);
• fortuitously, on parts of prostatic resection during the surgical treatment of prostatic adenoma.

When symptomatic, prostate cancer is most often at an advanced stage. It can lead to:

• acute urinary retention  ;
• hematuria  ;
• sexual impotence  (erectile dysfunction);
• a  deterioration of the general condition  ;
• of pain and/or the malfunction or failure of other organs related to the presence of  metastases .

Radiotherapy is one of the treatments conventionally offered in prostate cancer

External or internal radiotherapy?

A second option in the treatment of localized prostate cancer is radiation therapy.

Two types of radiotherapy are used to treat this pathology, external radiotherapy and internal radiotherapy also called brachytherapy or brachytherapy.

The external radiation corresponds to conventional radiation: radiation from an external source are directed so focused on the patient's tumor. The dose of radiation needed to destroy the tumor is delivered over several sessions, often five per week for one to two months.

Internal radiation therapy is based on the implantation of radioactive needles into the prostate. The needles are put in place during surgery, under general anesthesia. This method has the advantage of sparing the organs neighboring the prostate since the radioactive radiation is delivered directly into the prostate gland.

The various complications of radiotherapy are described in the chapter devoted to radiotherapy and accessible in the  treatment section  itself in the health section of the site.

External radiotherapy and brachytherapy are among the potentially curative therapeutic modalities offered in the treatment of non-metastatic prostate cancer. Few data have been published on their management and their prevention is essential. An assessment as precise as possible of the risk / benefit ratio is necessary before any treatment decision and clear and objective information for the patient must be made, including the risk of late morbidity and the possible impact of late side effects on quality of life.

The immediate digestive side effects during irradiation are very frequent and almost constant even if they are mostly very moderate and with limited impact. They consist of transit disorders sometimes linked to enterocolitis and accompanied by abdominal pain and above all by a rectal syndrome with a fractionation of the stools which become mucus and some false needs. Patients with hemorrhoids develop anal discomfort earlier and more readily, sometimes with bleeding and should be treated early.

Most of these side effects disappear a few weeks after the end of the irradiation.

Late complications are much rarer, around 7 to 10% for grade 1-2 complications and have become exceptional for serious complications (3.5% grade 3 and 0.5% grade 4). These late complications, when they occur, are essentially anorectal, with the risk of enteritis only occurring when large volumes of hail have been included in a large volume of pelvic irradiation. The evaluation of these complications is done according to the score, LENT SOMA (Late Effects on Normal Tissue Scale) of the RTOG-EORTC:

Grade 1:  no change.

Grade 2:  mild diarrhea; some colic pain; less than 5 bowel movements per day; mucus stool.

Grade 3:  moderate diarrhea; more than 5 bowel movements per day; mucous or haemorrhagic proctitis.

Grade 4:  obstruction or rectal bleeding requiring surgery.

Grade 5:  necrosis, perforation, fistula.
 

Urinary complications from radiotherapy are rare even if during irradiation, irritative phenomena are very frequent. However, it is the rule not to irradiate a very large adenomatous prostate in patients with high IPSS, otherwise, a retention syndrome may occur during treatment. The removal of the previous obstacle will call for the usual medical or surgical treatments. The start of irradiation should be postponed after a transurethral resection to avoid increasing the risk of urinary incontinence or subsequent stenosis and will not begin until after complete healing of the resection pocket, generally in the third month. 

We deliver all over the world. 

For more information, you can contact our experts on +229 51374202 direct line or by WhatsApp at the same number.

PROSTATE CANCER: TERMINAL PHASE SYMPTOMS

Prostate cancer is the most common cancer, both in men and in the general population. First signs, causes, diagnosis and treatment ... Lighting from Pierre-Olivier Bosset, urological surgeon.

Definition: location and role of the prostate

The prostate is a gland in the male reproductive system that plays a hormonal role and in the production of sperm. The appearance of prostate cancer corresponds to the transformation of prostate cells. Initially healthy, they multiply in an anarchic manner until they form a malignant tumor. In 95% of cases, the cancers are in the histological form of adenocarcinoma which develops from the cells making up the lining tissue of the prostate. If cancer starts out in the prostate, the tumor can then grow and invade other parts of the body.

Stadiums

The course of this disease is often slow. As with all cancers, there are several stages of development. The evolution of cancer can be local or distant depending on the time of diagnosis. Prostate cancer can range from stage 1 to 4 depending on how far it has spread. It is with a view to saving more human lives that Dawasanté experts provide you with a mixture of seeds, roots and bark from Africa to prevent and cure prostate cancer. Click on the image below to discover this natural treatment

Prostate cancer in numbers

Cancer of the prostate is the most common cancer. In 2015, 50,430 new cases were diagnosed (InVs figures). With 8,512 deaths in 2015, it ranks third among cancer deaths in humans. More than 5 out of 10 prostate cancers are linked to a hereditary predisposition. The average age of prostate cancer is around 60-70 years,  but some men are affected at an earlier age. A decrease in mortality from prostate cancer has been observed since 2000. The improvement in treatment largely explains the reasons for this decrease. 

Symptoms

Often, early-stage prostate cancer does not have any symptoms or signs. It is usually detected by a PSA scan or by a DRE, a process called detection. If prostate cancer is suspected based on a PSA or DRE scan, more checks and tests are needed to diagnose prostate cancer. When prostate cancer effectively causes symptoms or signs, it is usually diagnosed at a   later stage. These signs and symptoms include:  

Frequent urination

Poor or interrupted urination flow, or need to exert force to empty the bladder.

Urge to urinate frequently at night.

Blood in the urine

Blood in seminal fluid.

· New appearance of erectile dysfunction.

Pain or burning sensation when urinating, which is much less common.

Discomfort or pain when sitting caused by an enlarged prostate.

• voiding pain, 
• hematuria,
• dysuria.

Sometimes men with prostate cancer don't have any of these changes. Other non-cancerous prostate conditions, such as BPH or an enlarged prostate, can produce similar symptoms. Or the cause of these symptoms may be some other medical condition other than cancer. Urinary symptoms can also result from a bladder infection or other conditions.

If cancer has spread outside of the prostate, a man may feel:

Pain in the back, hips, thighs, shoulders, or other bones.

Swelling or accumulation of fluid in the legs or feet.

· Weight loss for no apparent reason.

· Tired

· Change bowel habits.

If you are concerned about any changes you have experienced, tell your doctor Your doctor will ask you since when and how often you have had the symptom (s), among other questions. This helps to find the cause of the problem, which is called the diagnosis.

This cancer is sometimes never discovered during the patient's lifetime. It is therefore only at  a more advanced stage of development  that the first symptoms appear

PSA screening and assay: recommendations on age and frequency

As age is a major risk factor,  men over 60  are subject to increased medical surveillance. The rectal examination is the most effective method for detecting the possible presence of a mass in the prostate.

Regularly or in case of doubt, the doctor also recommends a  blood test of the level of Prostate Specific Antigen (PSA), the main reflection of the functioning of the prostate gland. " In the interview, it is also necessary to look for other risk factors for prostate cancer: family background (history of prostate cancer) and ethnic origins (DOM-TOM, Africans) ", explains Dr. Pierre-Olivier Bosset, surgeon urologist. The PSA assay, a prostate-specific antigen, is a protein produced exclusively by the prostate which makes it possible to suggest the diagnosis and to monitor the progression of prostate cancer. This is a very sensitive assay in cancer screening.

THE PHASES OF CANCER

The stages of cancer range from the first mutations of cells until the disease reaches its final stage. This is known as natural history.

WHAT ARE THE PHASES OF CANCER?

The duration of this process in adults depends on the type of cancer and ranges from a few months to several decades. In the case of children, this whole process goes much faster and may even last only a few months. In fact, the cells that make up tumors in children are more immature cells that divide and multiply more quickly than those that make up adult cancers so that tumors develop and grow in children. in a short period of time.

STEP 0

The first thing that happens is the cellular changes that give the cells the characteristics of malignancy, that is, uncontrolled multiplication and the ability to invade. This is the longest phase of the disease and is called the induction phase. In no case is it diagnosable or produces symptoms. This phase can last up to 30 years.

STEP I

The second step is called the "in situ" phase. It is characterized by the existence of the microscopic cancerous lesion located in the tissue where it originates. In adults, it usually lasts between 5 and 10 years depending on the type of cancer. 

In it, there are no symptoms or discomfort in the patient. In some cases, such as breast, cervical or colon cancer, the disease can be diagnosed at this stage using techniques that allow for early detection.

STEP-II

Subsequently, the lesion begins to spread outside its place of origin and invades adjacent tissues or organs. We are facing the local invasion phase. In adulthood, it lasts between 1 and 5 years. The appearance of symptoms of the disease depends on the type of cancer, how it is growing, and where it is.

METASTASIS

Finally, the disease spreads outside its place of origin as distant tumor lesions called metastases. This is the stage of the remote invasion. The symptomatology presented by the patient is generally complex. It depends on the type of tumor, location and extent of metastasis.             

STEP IV: TERMINAL PHASE

This phase is characterized by the existence of advanced,   irreversible and irreversible   (incurable) cancer. It is also referred to as terminal cancer.

It does not respond to commonly used treatments. It is accompanied by multiple symptoms that cause great discomfort in the patient, affecting his quality of life and that of his family.

It is a time of intense pain, but also of transcendental importance. If the patient and his family have prepared, this time makes it easier to reunite with oneself and with loved ones.

The area of ​​medicine that deals with the care of patients at this stage of illness is that of palliative care or palliative medicine.

HOW DOES CANCER EVOLVE?  

The course of each cancer is subject to multiple factors that will interact with each other. These factors vary depending on the tumor and the patient.   

Remember that "  there are no diseases, but sick people    ."